baber/WOPTO huggingface dataset:
Patent NZ-550555-A (NZ)
Title: Thio-substituted biaryl-methanesulfinyl derivatives
Inventor: BACON EDWARD R
IPC: C07D213/34
Filed: 2005-04-13
Abstract: Disclosed is a compound of Formula (I) wherein Y is -CH2-, -CH(OCH-3)-, -CH2CH2-; R1 is selected from H, C(=O)NR12R13, and C(=O)OR11; R4 and R5 are H; q is 1 or 2; and wherein the rest of the substituents are disclosed within the specification. Also disclosed is the use of the compound of Formula (I) for manufacturing a medicament for treating sleepiness associated with narcolepsy, obstructive sleep apnea, or shift work disorder; Parkinson's disease; Alzheimer's disease; attention deficit disorder; attention deficit hyperactivity disorder, depression; or fatigue.
Patent NZ-555344-A (NZ)
Title: A modular intervertebral implant that articulates using nesting spherical surfaces that is constructed from a kit of parts to have a selectable centre of rotation position
Inventor: LECHMANN BEAT
IPC: A61F2/44
Filed: 2005-12-27
Abstract: A modular intervertebral implant is disclosed. The implant articulates using nesting spherical surfaces (9, 10) and is constructed from a kit of parts to have a selectable centre of rotation position (RZ). Each half (3, 4) of the implant has an apposition area (5, 6) to abut an adjoining vertebrae. Each half is selected from a kit of parts with the same spherical surface shape, concave or convex, that have different heights (H1, H2). In this way a custom implant may be constructed whose centre of rotation (RZ) is positioned where needed, at the distance (A) from the bottom of the lower half. The overall height of the implant (H) is always less than the sum of the heights of the two parts (H1+H2).
Patent NZ-556342-A (NZ)
Title: 1-thio-d-glucitol derivatives
Inventor: KAKINUMA HIROYUKI
IPC: A61K31/382
Filed: 2006-01-10
Abstract: Disclosed is a 1-thio-D-glucitol compound of formula I, or a pharmaceutically acceptable salt thereof, or a hydrate of the compound or the salt, wherein the substituents are defined in the specification, which inhibit the activity of sodium-dependent glucose co-transporter 2 (SGLT2) concerned with glucose re-absorption in the kidney.
Patent NZ-562304-A (NZ)
Title: Extrusion process for making compositions with poorly compressible therapeutic compounds e.g. metformin hydrochloride
Inventor: VASANTHAVADA MADHAV
IPC: A61K31/155
Filed: 2006-05-08
Abstract: Disclosed is a process for making an immediate-release pharmaceutical composition comprising the steps of: combining the poorly compressible therapeutic compound metformin hydrochloride with at least one granulating component to form a mixture, wherein said granulating component is a polymer having a Tg less than the melting point of said therapeutic compound; kneading said mixture in an extruder while heating said mixture to a heating temperature less than the melting point of said therapeutic compound and greater than or equal to the Tg of said polymer; extruding said mixture to form granules; and compressing said granules to form a solid oral dosage form. This process is also suitable for improving the friability of a tablet containing a poorly compressible therapeutic compound metformin hydrochloride.
Patent NZ-564028-A (NZ)
Title: Processes for the preparation of 1-chloro-4-(D-glucopyranos-1-yl)-2-(4-tetrahydrofuran-3-yloxy-benzyl)-benzene derivatives and intermediates therein
Inventor: HIMMELSBACH FRANK
IPC: C07H15/203
Filed: 2006-05-10
Abstract: Disclosed are methods for the preparation of 1-chloro-4-(b-D-glucopyranos-1-yl)-2-(4-(R)-tetrahydrofuran-3-yloxy-benzyl)-benzene and 1-chloro-4-(b-D-glucopyranos-1-yl)-2-(4-(S)-tetrahydrofuran-3-yloxy-benzyl)-benzene (which relates to the general formula XXXIII) where R1 is tetrahydrofuran-3-yl); wherein the process involves the use of compounds of formula V, where X denotes a bromine atom or an iodine atom, and R1 is as defined above. Further disclosed is a process for the preparation of the compounds of formula V from the compounds (5-bromo-2-chloro-phenyl)-(4-fluoro-phenyl)-methanone or (5-iodo-2-chloro-phenyl)-(4-fluoro-phenyl)-methanone.
Patent NZ-568644-A (NZ)
Title: Fungicidal composition containing carboxylic acid amide derivative
Inventor: NAKAMURA YUJI
IPC: A01N37/26
Filed: 2006-12-13
Abstract: Disclosed is a fungicidal composition containing a carboxylic acid amide derivative of the formula (I) or a salt thereof as an active ingredient wherein B is a 2- or 3- pyridyl which may be substituted; A is a phenyl, benzodioxolanyl or benzodioxanyl which may be substituted by X; and wherein the rest of the substituents are disclosed within the specification.
Patent NZ-577198-A (NZ)
Title: Storing logdata efficiently while supporting querying to assist in computer network security
Inventor: HUANG WEI
IPC: G06F11/34
Filed: 2007-12-28
Abstract: A computer-implemented method for processing log data (340) is disclosed. The method comprises receiving log data that comprises a plurality of events for each event in the plurality of events the event in a buffer (360) is stored and a metadata structure (365) that comprises information on the content of the buffer comprising the stored event(s) is updated. An event comprises one or more fields and the information comprises a first minimum value that indicates a minimum value of a first field of all of the events stored in the buffer. Further disclosed is an apparatus for processing log data comprising a processor coupled to computer-readable storage medium storing executable program code that when executed by the processor the above described method is performed.
Patent NZ-577314-A (NZ)
Title: A collapsible trawl netting arrangement
Inventor: GALLAGHER DANNY
IPC: A01K73/02
Filed: 2007-09-21
Abstract: Disclosed is a trawl netting arrangement. The arrangement includes a main netting component and at least one grid portion formed from a series of loops. Each loop has four sides, two sides of each loop are formed from longitudinally arranged substantially parallel rigid sides and the other two sides are flexible sides. The flexible sides interconnect between the rigid sides. The grid can be collapsed by compressing the flexible sides and bringing together the rigid sides.
Patent NZ-578077-A (NZ)
Title: Diagnosis of preeclampsia using free foetal haemoglobin
Inventor: HANSSON STEFAN
IPC: A61K38/42
Filed: 2008-02-12
Abstract: Disclosed is the use of free foetal haemoglobin as a marker for (i) diagnosing preeclampsia, (ii) monitoring the progression or regression of preeclampsia and (ii) assessing the efficacy of a treatment of preeclampsia.
Patent NZ-584622-A (NZ)
Title: Compositions comprising apomorphine and magnesium stearate for treating parkinson's disease
Inventor: GANDERTON DAVID
IPC: A61K9/14
Filed: 2008-10-31
Abstract: Disclosed is the use of a composition of apomorphine and magnesium stearate for preventing or treating the symptoms of Parkinson's disease, wherein the composition is for pulmonary inhalation and comprises a Nominal Dose of apomorphine of at least 0.8 mg and up to 11.5 mg providing a fine particle dose in the order of 0.5 mg to 7 mg.
Patent NZ-586547-A (NZ)
Title: Wastewater trap with a one way duckbill valve and liquid based seal
Inventor: MCALPINE JAMES EDWARD
IPC: E03C1/288
Filed: 2008-12-22
Abstract: 586547 A plumbing sealing arrangement or trap or waste outlet with a duckbill valve to provide an improved liquid seal. The arrangement comprises a passageway having an inlet adapted to be connected to a waste outlet and an outlet adapted to be connected to a soil stack and a duck bill shaped one-way valve located between the passageway inlet and outlet. The one-way valve is adapted to permit the passage of fluid through the passageway in one direction only from the inlet to the outlet. A trap is arranged to permit a liquid seal to be formed between the passageway inlet and the passageway outlet where in normal use, at least a portion of the one-way valve is immersed in the liquid seal.
Patent NZ-587593-A (NZ)
Title: Process for the manufacture of [phenylsulfanylphenyl]piperidines
Inventor: ROCK MICHAEL HAROLD
IPC: C07D211/52
Filed: 2009-03-02
Abstract: Disclosed is a process wherein a 2-(4-alkylphenylsulfanyl)-phenyl halide of formula II wherein R' and R" independently represent one, two or three hydrogen, halogen, alkyl, alkylene and L represents a leaving group is reacted with an N-benzyl-4-piperidone wherein R'" represents hydrogen or -O-alkyl, to obtain a compound of formula III. Also disclosed are 1-benzyl-4-hydroxy-4-[2-(4-methylphenylsulfanyl)phenyl]piperidine and 4-ethoxycarbonyloxy-4-(2-p-tolylsulfanyl-phenyl)-piperidine-1-carboxylic acid ethyl ester; and acid addition salts thereof.
Patent NZ-591957-A (NZ)
Title: A breath activated inhaler
Inventor: SMARTT NICHOLAS
IPC: A61M15/00
Filed: 2009-10-07
Abstract: 591957 Disclosed are an inhaler; a method of priming an inhaler and a method of a medicament from an inhaler. The breath activated inhaler ensures that sealed medicament compartments (16) are properly aligned with the outlet prior to releasing the medicament (16) to the patient, and indexes the next compartment (16) into alignment with the outlet so that next time the patient uses the inhaler; a dose is ready for delivery. The inhaler comprises an outlet; a plurality of sealed compartments (16) containing medicament; an opening mechanism (32); an indexing mechanism and a latch (56). The opening mechanism (32) moves between an energised position and an unloaded position. During movement from the energized position to the unloaded position the opening mechanism (32) opens a sealed compartment (16) aligned with the outlet. The indexing mechanism sequentially aligns the compartments (16) with the outlet. The indexing mechanism is adapted to align the next compartment (16) with the outlet after the opening mechanism (32) has been moved from the unloaded position to the energised position. The latch (56) moves between a first position and a second position. In the first position, the latch (56) latches the opening mechanism (32) in the energised position. In the second position the latch (56) allows the opening mechanism (32) to move to the unloaded position. The latch (56) is partly arranged in a flow path such that an inhalation flow through the flow path affects the latch (56) to move from the first position to the second position. The latch (56) is prevented from returning to the first position before the indexing mechanism has aligned the next compartment (16) with the outlet. A catch connected to and movable with the indexing mechanism prevents the latch (56) from reaching the first position.
Patent NZ-594120-A (NZ)
Title: Waste disposal control system
Inventor: WHITE ANTHONY
IPC: G05B11/01
Filed: 2011-07-18
Abstract: A Waste Disposal Control System (WDCS) that independently controls the water entering the waste disposal unit and the unit motor is disclosed. The WDCS (0), housed in a single box (1) has a low AC or DC voltage Solenoid (2) that switches the water supply. The power supply is via two standard 240v or 110 v three pin IPC plugs mounted on the adjacent face of the box (1) to the Solenoid. The male electrical socket (6) connects to the mains power supply (11), which the waste disposal (WD) (12) was previously connected to, and the female electrical socket (7) connects to the WD. The output of the solenoid is connected with a flexible hose to the existing inlet (10) of the WD by removing the “knock out” disc, designated as the “Dishwasher Drain” connection at the mouth of the WD (12). In use, when disposal of items in the sink (13) is desired, the WD switch (11) is turned on and the solenoid is activated sending water to the WD blades. After a delay of zero or greater seconds the motor of the WD is turned on. This control prevents blockages and miss-operation caused by the activation of the WD without water flowing. Various delays to the operation of the solenoid and WD are disclosed.
Patent NZ-600418-A (NZ)
Title: Multi-species insect trap with separated plumes
Inventor: SCHNEIDMILLER RODNEY G
IPC: A01M1/02
Filed: 2010-12-13
Abstract: 600418 An insect trap (300) is disclosed. The insect trap comprises an entrapment chamber (210) having open first and second ends. A first entry structure is removably attached to the first end of the entrapment chamber, which allows entry of a target insect. The first entry structure includes an upper lid (222) having a large aperture, an entry cone (226) disposed below the large aperture, and an attractant holder configured to retain a first insect attractant. A lower lid (342) is removably attached to the second end of the entrapment chamber. The lower lid includes a plurality of apertures (343) and a means for retaining a second insect attractant.
Patent NZ-612870-A (NZ)
Title: Enhanced measurement gap configuration support for positioning
Inventor: KAZMI MUHAMMAD
IPC: H04W24/00
Filed: 2011-07-01
Abstract: Disclosed is a method implemented by a base station (40-s) configured to serve a wireless device (36) in a serving cell (42-s) of a wireless communication system (30) on a serving frequency. The method comprises obtaining information that indicates one or more non-serving frequencies on which the wireless device (36) is to perform one or more positioning measurements that are to be used for determining the wireless device’s (36) geographic position; and for at least one non-serving frequency indicated by the information, configuring a measurement gap during which the wireless device (36) is to perform a corresponding positioning measurement to occur during a period of time in which a neighbouring cell (42-1, 42-2) transmits a positioning reference signal over that non-serving frequency. The obtaining process comprises receiving at least some of the information within a request from the wireless device (36) requesting that the base station (40-s) configures one or more measurement gaps during which the wireless device (36) is to perform the one or more positioning measurements on the one or more non-serving frequencies.
Patent NZ-612968-A (NZ)
Title: Systems and methods for creating and using a research map
Inventor: SHARMA SANJAY
IPC: G06F17/30
Filed: 2011-12-08
Abstract: Systems and methods create a graphical representation of a research map that allows performance of search functions using the nodes of the graphical representation is disclosed. The system includes a processor and a memory. The memory stores instructions that cause the processor to receive a query for searching a document repository and run the query in the document repository. The processor stores the results of the query and the query as a root node (205) in a research tree. The processor receives a filter for the results of the query. The processor stores the filter and the result list for the filter as a filter node (210, 215, 220) connected to the root node of in the research tree. The processor receives a request to view a document from the result list for the filter and stores the request as a document node connected to the filter node (225, 230, 235, 240, 245). The processor then creates a display of a research map that includes the research tree.
Patent NZ-619241-A (NZ)
Title: Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
Inventor: SHALWITZ ROBERT
IPC: A61P35/00
Filed: 2012-06-05
Abstract: Disclosed herein is { [5-(3-fluorophenyl)-3-hydroxypyridine-2-carbonyl]-amino} acetic acid and it’s compositions, that can stabilize hypoxia inducible factor-2 alpha (HIF-2a) and thereby provide a method for treating cancer. Further disclosed are compositions which comprise { [5-(3-fluorophenyl)-3-hydroxypyridine-2-carbonyl]-amino} acetic acid and/or a prodrug thereof which can be used to treat cancer.
Patent NZ-626149-A (NZ)
Title: Long-acting injectable moxidectin formulations and novel moxidectin crystal forms
Inventor: CADY SUSAN MANCINI
IPC: C07D493/22
Filed: 2012-11-30
Abstract: Disclosed herein are antiparasitic and pesticidal solid forms of moxidectin, including a long-acting polymeric implant. The resulting compounds may be used in veterinary compositions which are used in treating, controlling and preventing of endo- and ectoparasite infections in animals. The disclosure particularly relates to moxidectin polymorphic A form having a melting point of 210°C, prepared by the process of providing amorphous moxidectin, immersing the moxidectin into an oil bath at 190°C for about 2 to about 10 minutes, and cooling the moxidectin, thereby preparing the polymorphic A crystalline form of moxidectin.
Patent NZ-703122-A (NZ)
Title: Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate
Inventor: KASPER LLOYD H
IPC: G01N33/68
Filed: 2011-10-10
Abstract: method of predicting clinical responsiveness to glatiramer acetate therapy in a human subject afflicted with multiple sclerosis or a single clinical attack consistent with multiple sclerosis comprises evaluating a biomarker selected from the group consisting of IL-17 concentration, TNF-alpha concentration, IL-2 concentration and IFN-gamma concentration, or a combination thereof, in the supernatant of PBMCs derived from the subject’s blood, and identifying the human subject as a glatiramer acetate responder based on the biomarker. The subject can be identified as a glatiramer acetate responder by steps comprising i) purifying PBMCs from the subject’s blood and then cryopreserving the PBMCs; ii)thawing and then culturing the cryopreserved PBMCs overnight in culture medium supplemented with 5% human serum; iii) stimulating 40,000 of said cultured PBMCs with 1 mg/ml PMA and 5 mg/ml ionomycin in a final volume of 200 microliters for 6 hours; and iv) identifying the human subject as a glatiramer acetate responder a)if the IL-17 concentration of the supernatant of PBMCs after step (iii) is greater than or equal to 120 pg/ml, b) if the TNF-a concentration of the supernatant of PBMCs after step (iii) is greater than or equal to 20000 pg/ml, c) if the IFN-y concentration of the supernatant of PBMCs after step (iii) is greater than or equal to 6000 pg/ml, or d) if the IL-2 concentration of the supernatant of PBMCs after step (iii) is greater than or equal to 30000 pg/ml, thereby predicting clinical responsiveness to glatiramer acetate.
Patent NZ-703925-A (NZ)
Title: Pandemic protocol for emergency dispatch
Inventor: CLAWSON JEFFREY J
IPC: G06Q50/22
Filed: 2013-08-19
Abstract: Systems and methods are provided to guide an emergency dispatcher in responding to emergency calls involving a patient manifesting symptoms of a pandemic illness. Existing methods and systems offer little to facilitate providing an appropriate emergency response to an emergency situation involving a pandemic illness. More particularly, present systems and methods do not facilitate providing accurate, consistent, and systematic processing of emergency calls involving a pandemic illness. In one aspect, a computer-implemented method comprises presenting on a dispatch center computer device a pre-scripted interrogation comprising a plurality of preprogrammed inquiries for the dispatcher to ask the caller to systematically obtain a description of the medical emergency including information concerning symptoms of the pandemic illness that the patient is manifesting, the description of the medical emergency comprising caller responses to the plurality of preprogrammed inquiries, wherein the dispatch center computer device includes a logic tree configured to determine the preprogrammed inquiries of the pre-scripted interrogation and automatically determine one of a plurality of pre-established determinant values based on dispatcher-entered input representative of caller responses to the preprogrammed inquires; presenting preprogrammed inquiries of the pre-scripted interrogation, via a user interface on an output device of the dispatch computer device, as the method traverses a path along the logic tree of the pre-scripted interrogation based on caller responses to the preprogrammed inquiries, and wherein the path along the logic tree ends at the pre-established determinant value; receiving dispatcher-entered input on the dispatch center computer device representative of caller responses to the preprogrammed inquiries of the pre-scripted interrogation; the preprogrammed inquiries providing an instruction to the dispatcher to enter the locally designated pandemic triage level; the preprogrammed inquires providing an instruction to the dispatcher to enter the most prominent complaint of the patient; the dispatch centre computer device operating a diagnostic tool to determine whether the patient likely is infected with the pandemic illness based on the responses to the preprogrammed inquiries; the dispatch centre computer device operating a determinant value calculator to calculate a pre-established determinant value from the responses of the caller and the locally designated pandemic triage level, wherein the determinant value provides a categorisation code of the type and level of the incident; generating an emergency medical dispatch response by emergency responders based on the determinant value; and communicating the determinant value to the emergency responders.
Patent NZ-705636-A (NZ)
Title: Hot beverage brewing system and use thereof
Inventor: BOMBECK KHRISTIAN
IPC: A47J31/043
Filed: 2012-02-24
Abstract: A method for brewing a beverage, in particular the type of machine which may be known as a vacuum pot coffee maker or siphon coffee maker. The method consisting of: method of brewing a beverage, the method comprising the steps of: providing a heated fluid into a lower chamber of the brewing device from a boiler of the brewing device; providing an agitation fluid into the lower chamber, the agitation fluid forcing the heated fluid into an upper chamber of the brewing device; providing the agitation fluid into the upper chamber by forcing the heated fluid through a conduit of the brewing device, the conduit having a first open end disposed at a lower end of the lower chamber and the second open end disposed at a lower end of the upper chamber; adding a flavor base into the upper chamber; combining the heated fluid with the flavor base, forming a brewed beverage; and dispensing the brewed beverage. Wherein the brewing device comprises (a) a common inlet in fluid communication with the lower chamber, the upper chamber, the boiler, and the conduit, the common inlet providing an inlet from the lower chamber, the boiler, and the conduit to the upper chamber, and (b) a vent operable between a closed position and an open position, wherein, in the open position, the vent provides fluid communication between the lower chamber and atmosphere.
Patent NZ-710699-A (NZ)
Title: Leak detectable geomembrane liners for containment system and method of testing for leaks
Inventor: YOUNGBLOOD JIMMIE
IPC: B65D90/04
Filed: 2014-01-21
Abstract: A geomembrane liner for a containment system which may be tested for electrical current above the liner to detect leaks. The liner has multiple liner panels connected by seams at overlapped edges in a manner which prevents electrical current from leaking through the seam with the top panel of a seam having a conductive lower surface which is non-conductive across the seam. This prevents electrical current in the conductive bottom of a top panel from passing to the top of the liner by preventing current from passing through the seam to a location above the underlying, bottom panel adjacent the seam. Heat welding of the seams may be accomplished by a welder having a heating unit with a projection which interrupts the conductive lower surface of the top panel before forming the seam. Such seams may be used separately or selectively with a lined containment system having a plurality of liner panels covering at least a portion of the containment system bottom. The liner panels have a conductive lower surface and overlap with adjacent panels, and conductive members may underlie adjacent panels and contact the conductive lower surface of both adjacent panels to provide an electrical connection between the conductive lower surfaces of the adjacent panels.